KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 248 filers reported holding KARUNA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $416,469 | -20.7% | 2,463 | +1.7% | 0.00% | -50.0% |
Q2 2023 | $525,211 | -53.5% | 2,422 | -61.0% | 0.00% | -33.3% |
Q1 2023 | $1,128,529 | -14.7% | 6,213 | -7.7% | 0.00% | -40.0% |
Q4 2022 | $1,322,838 | -4.4% | 6,732 | +9.5% | 0.01% | 0.0% |
Q3 2022 | $1,384,000 | +107.5% | 6,150 | +16.5% | 0.01% | +150.0% |
Q2 2022 | $667,000 | -27.3% | 5,279 | -27.2% | 0.00% | 0.0% |
Q1 2022 | $918,000 | -22.3% | 7,248 | -19.6% | 0.00% | 0.0% |
Q4 2021 | $1,182,000 | +5.5% | 9,017 | -1.6% | 0.00% | -33.3% |
Q3 2021 | $1,120,000 | -11.1% | 9,159 | -17.1% | 0.00% | -25.0% |
Q2 2021 | $1,260,000 | +31.7% | 11,053 | +38.9% | 0.00% | +33.3% |
Q1 2021 | $957,000 | +23.3% | 7,960 | +4.2% | 0.00% | 0.0% |
Q4 2020 | $776,000 | +61.3% | 7,636 | +22.7% | 0.00% | +50.0% |
Q3 2020 | $481,000 | -31.3% | 6,223 | -0.9% | 0.00% | -50.0% |
Q2 2020 | $700,000 | +131.8% | 6,282 | +49.6% | 0.00% | +100.0% |
Q1 2020 | $302,000 | -35.9% | 4,199 | -32.8% | 0.00% | 0.0% |
Q4 2019 | $471,000 | – | 6,247 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |